Brief: Mankind Pharma March-Quarter Consol Net Profit At 4.71 Billion Rupees

Mankind Pharma

15/05/2024 15:36

May 15 (Reuters) - Mankind Pharma Ltd  MNKI.NS :
    * MANKIND PHARMA MARCH-QUARTER CONSOL NET PROFIT 4.71
BILLION
RUPEES; LSEG IBES PROFIT EST. 3.88 BILLION RUPEES
    * MANKIND PHARMA MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS
24.41 BILLION RUPEES; LSEG IBES EST. 24.08 BILLION RUPEES
    * MANKIND PHARMA YEAR AGO MARCH-QUARTER CONSOL PROFIT 2.85
BILLION
RUPEES, REVENUE 20.53 BILLION RUPEES

Source text for Eikon:  ID: 
Further company coverage:  MNKI.NS 

 ((Reuters.Briefs@thomsonreuters.com;))